Glenn Saldanha, chief of Glenmark Pharmaceuticals, has struck a hatrik with Glenmark Pharmaceuticals signing 3 alliances in just five days. The latest one being Glenmark Generics' exclusive license and supply agreement with Taro Pharmaceuticals USA Inc.